Kancera AB (publ) 3EE0.F Stock
Kancera AB (publ) Price Chart
Kancera AB (publ) 3EE0.F Financial and Trading Overview
| Kancera AB (publ) stock price | 0.12 EUR |
| Previous Close | 0.23 EUR |
| Open | 0.22 EUR |
| Bid | 0.22 EUR x N/A |
| Ask | 0.25 EUR x N/A |
| Day's Range | 0.22 - 0.22 EUR |
| 52 Week Range | 0.16 - 0.57 EUR |
| Volume | 2K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 19.19M EUR |
| Beta (5Y Monthly) | 1.23908 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
3EE0.F Valuation Measures
| Enterprise Value | 18.09M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Kancera AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.23908 |
| 52-Week Change | -54.078% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.57 EUR |
| 52 Week Low | 0.16 EUR |
| 50-Day Moving Average | 0.25 EUR |
| 200-Day Moving Average | 0.27 EUR |
3EE0.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 81.51M |
| Float | 76.43M |
| Short Ratio | N/A |
| % Held by Insiders | 20.89% |
| % Held by Institutions | 4.71% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -31.76% |
| Return on Equity (ttm) | -57.99% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.455 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Kancera AB (publ)
| Country | Germany |
| State | N/A |
| City | Solna |
| Address | Karolinska Institutet Science Park |
| ZIP | 171 65 |
| Phone | 46 8 50 12 60 80 |
| Website | https://www.kancera.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Kancera AB (Publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops HDAC for the treatment of nerve inflammation and pain; and ROR1 inhibitors for the treatment of solid tumors and blood cancers. Kancera AB (Publ) was founded in 2010 and is based in Solna, Sweden.
Q&A For Kancera AB (publ) Stock
What is a current 3EE0.F stock price?
Kancera AB (publ) 3EE0.F stock price today per share is 0.12 EUR.
How to purchase Kancera AB (publ) stock?
You can buy 3EE0.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kancera AB (publ)?
The stock symbol or ticker of Kancera AB (publ) is 3EE0.F.
Which industry does the Kancera AB (publ) company belong to?
The Kancera AB (publ) industry is Biotechnology.
How many shares does Kancera AB (publ) have in circulation?
The max supply of Kancera AB (publ) shares is 142.82M.
What is Kancera AB (publ) Price to Earnings Ratio (PE Ratio)?
Kancera AB (publ) PE Ratio is now.
What was Kancera AB (publ) earnings per share over the trailing 12 months (TTM)?
Kancera AB (publ) EPS is -0.06 EUR over the trailing 12 months.
Which sector does the Kancera AB (publ) company belong to?
The Kancera AB (publ) sector is Healthcare.